Key result
Pathogenic TNNT2 variants linked to poor outcomes, with ~50% death or heart transplant.
Why the study?
Cardiomyopathies present with highly variable cardiac phenotypes, but genetic screening of family members is not yet performed routinely.
Observational (n=16)
Family genetic screening for TNNT2 variants in dilated cardiomyopathy reveals highly heterogeneous clinical phenotypes and enables earlier risk assessment and therapeutic intervention.
Answers are grounded in this paper and cite their sources.
TNNT2 variants may prompt family screening in dilated cardiomyopathy; extends limited prior data but remains hypothesis-generating.
Background: Cardiomyopathies (CMs) are a heterogeneous and severe group of diseases that shows a highly variable cardiac phenotype and an incidence of app. 1/100.000. Genetic screening of family members is not yet performed routinely. Patients and methods: Three families with dilated cardiomyopathy (DCM) and pathogenic variants in the troponin T2, Cardiac Type (TNNT2) gene were included. Pedigrees and clinical data of the patients were collected. The reported variants in the TNNT2 gene showed a high penetrance and a poor outcome, with 8 of 16 patients dying or receiving heart transplantation. The age of onset varied from the neonatal period to the age of 52. Acute heart failure and severe decompensation developed within a short period in some patients. Conclusion: Family screening of patients with DCM improves risk assessment, especially for individuals who are currently asymptomatic. Screening contributes to improved treatment by enabling practitioners to set appropriate control intervals and quickly begin interventional measures, such as heart failure medication or, in selected cases, pulmonary artery banding.
No takes yet. Share an insight, caveat, or question.
Weis et al. (2023) conducted an observational in Dilated cardiomyopathy with TNNT2 variants (n=16). Pathogenic TNNT2 variants was evaluated on Death or heart transplantation. Pathogenic variants in the TNNT2 gene were associated with high penetrance and poor outcomes, with 50% (8 of 16) of affected patients dying or requiring a heart transplantation.
Synapse has enriched 10 related papers. Consider them for comparative context: